Echo Guided Alcohol Septal Ablation (ASA) for Refracting Symptomatic HOCM – Oct 2015
79 year-old male with known hypertrophic obstructive cardiomyopathy (HOCM) with progressive exertional dyspnea NYHA CCS Class IIII and mild inferior wall ischemia on stress MPI. Echo revealed asymmetric septal hypertrophy (with septal thickness of 21mm) and systolic anterior motion (SAM) of anterior mitral valve leaflet, high LVOT gradient (rest gradient = 42mmHg; peak stress and Valsalva gradient = 141mmHg) hyperdynamic LV function (70%) and mild to moderate MR. MRI confirmed echo findings and also revealed systolic obliteration of LV cavity with scattered patchy minimal necrosis. Cardiac cath revealed 88 mmHg gradient at rest at mid cavity level with positive Brockenbrough-Braunwald-Morrow sign with gradient of 190 mmHg and moderate mid LAD lesion. Patient remains symptomatic despite being on maximum tolerated dose of calcium channel blocker (& is intolerant to beta blocker). Patient is now planned for echo guided alcohol septal ablation (ASA) for refracting symptomatic HOCM.
Mitral ViV TMVR using SAPIEN-3 Valve – May 2019
81 year old female presents with worsening dyspnea on minimal exertion (NYHA class III) over the last few months. Her past medical history is significant for rheumatic heart disease with severe MR and MS s/p bioprosthetic MVR with 29 mm porcine valve (Biocor, St. Jude Medical) along with MAZE procedure in 2007. She also has […]
Valve-in-Valve TAVR with 26mm SAPIEN-3 – March 2019
79 year old man presents with worsening exertional dyspnea (NYHA Class III) for the last 3 months. Patient has required multiple recent admissions to hospital with CHF exacerbation requiring IV diuretics. Past medical history is significant for symptomatic bicuspid aortic valve with dilated ascending aorta s/p Bentall procedure (2011) with 25 mm Carpentier-Edwards pericardial valve […]
Valve-in-Valve TAVR with 29mm Evolut-R CoreValve – January 2019
79 year old man presents with progressive exertional dyspnea (NYHA Class III) for the last 2 months.